Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3β and attenuated by lithium
暂无分享,去创建一个
[1] A Hartley,et al. Complex I Inhibitors Induce Dose‐Dependent Apoptosis in PC12 Cells: Relevance to Parkinson's Disease , 1994, Journal of neurochemistry.
[2] J W Langston,et al. MPTP: current concepts and controversies. , 1986, Clinical neuropharmacology.
[3] E. Hirsch,et al. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] B. Jortner,et al. Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells. , 1997, Neurotoxicology.
[5] D. Chuang,et al. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats , 1998, Neuroreport.
[6] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[7] A. Windebank,et al. Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. , 1998, Journal of neurobiology.
[8] R. Jope,et al. Glycogen Synthase Kinase-3β Facilitates Staurosporine- and Heat Shock-induced Apoptosis , 2000, The Journal of Biological Chemistry.
[9] L. Peso,et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.
[10] Colin B. Reese,et al. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase , 1997, Current Biology.
[11] A. Takashima. Tau protein I is essential for amyloid β-protein iduced neurotoxicity , 1993 .
[12] C. Fall,et al. MPP+ induced SH-SY5Y apoptosis is potentiated by cyclosporin A and inhibited by aristolochic acid , 1998, Brain Research.
[13] N. Harvey,et al. The role of caspases in apoptosis. , 1998, Advances in biochemical engineering/biotechnology.
[14] K. Siddle,et al. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. , 1998, The Biochemical journal.
[15] S. R. Datta,et al. Cellular survival: a play in three Akts. , 1999, Genes & development.
[16] D. Kimelman,et al. Role of Glycogen Synthase Kinase-3β in Neuronal Apoptosis Induced by Trophic Withdrawal , 2000, The Journal of Neuroscience.
[17] E. Wolvetang,et al. Mitochondrial respiratory chain inhibitors induce apoptosis , 1994, FEBS letters.
[18] A. Klippel,et al. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt , 1997, Molecular and cellular biology.
[19] B. Rosen,et al. NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals , 1996, Brain Research.
[20] G Cappelletti,et al. Involvement of tubulin in MPP+ neurotoxicity on NGF‐differentiated PC12 cells. , 1995, Cell biology international.
[21] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[22] X. Liu,et al. An APAF-1·Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9* , 1999, The Journal of Biological Chemistry.
[23] K. Imahori,et al. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. Quirion,et al. Insulin-like Growth Factor-1-induced Phosphorylation of the Forkhead Family Transcription Factor FKHRL1 Is Mediated by Akt Kinase in PC12 Cells* , 2000, The Journal of Biological Chemistry.
[25] W. Tatton,et al. Etiology and pathogenesis of Parkinson's disease. , 1999, Annual review of neuroscience.
[26] S. R. Datta,et al. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.
[27] R. Jope. Anti-bipolar therapy: mechanism of action of lithium , 1999, Molecular Psychiatry.
[28] R. Ramsay,et al. Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism. , 1986, Biochemical and biophysical research communications.
[29] E. Feldman,et al. Insulin‐like growth factor I rescues SH‐SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death , 1996, Journal of cellular physiology.
[30] L. Olson,et al. Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry , 1986, Brain Research Bulletin.
[31] Antonio Cuadrado,et al. Akt1/PKBα Protects PC12 Cells against the Parkinsonism-Inducing Neurotoxin 1-Methyl-4-phenylpyridinium and Reduces the Levels of Oxygen-Free Radicals , 2001, Molecular and Cellular Neuroscience.
[32] Sanford P. Markey,et al. Chronic parkinsonism secondary to intravenous injection of meperidine analogues , 1979, Psychiatry Research.
[33] R. Lindsay,et al. Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System , 1992, Journal of neurochemistry.
[34] C. Fall,et al. Characterization and time course of MPP+‐induced apoptosis in human SH‐SY5Y neuroblastoma cells , 1999, Journal of neuroscience research.
[35] Y. Kitamura,et al. Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells. , 1998, Molecular pharmacology.
[36] B. Vanhaesebroeck,et al. The PI3K-PDK1 connection: more than just a road to PKB. , 2000, The Biochemical journal.
[37] Muneesh Tewari,et al. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase , 1995, Cell.
[38] Y. Nomura,et al. Apoptosis induction by a dopaminergic neurotoxin, 1-methyl-4-phenylpyridinium ion (MPP(+)), and inhibition by epidermal growth factor in GH3 cells. , 2000, Biochemical pharmacology.
[39] Xiaohua Li,et al. Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. , 2002, Bipolar disorders.
[40] John Calvin Reed,et al. Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.
[41] David R. Kaplan,et al. Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.
[42] James R. Woodgett,et al. Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells , 1996, Current Biology.
[43] J. Gil,et al. Low concentrations of 1‐methyl‐4‐phenylpyridinium ion induce caspase‐mediated apoptosis in human SH‐SY5Y neuroblastoma cells , 2001, Journal of neuroscience research.
[44] D. Melton,et al. A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[45] K. Jellinger. Cell death mechanisms in Parkinson's disease , 2000, Journal of Neural Transmission.
[46] J. Sheehan,et al. MPP+ induced apoptotic cell death in SH‐SY5Y neuroblastoma cells: An electron microscope study , 1997, Journal of neuroscience research.
[47] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[48] G M Cohen,et al. Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.
[49] W. Nicklas,et al. IV. MPTP, MPP+ and mitochondrial function , 1987 .
[50] Emad S. Alnemri,et al. Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner , 1999, The Journal of cell biology.
[51] J C Reed,et al. Mitochondria and apoptosis. , 1998, Science.
[52] Mark P. Mattson,et al. Apoptosis in neurodegenerative disorders , 2000, Nature Reviews Molecular Cell Biology.
[53] Y. Nomura,et al. 1-Methyl-4-phenyl-pyridinium ion (MPP+) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SH-SY5Y cells, through different mechanisms , 1995, Brain Research.
[54] M. Tohyama,et al. Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide , 1998, Cell Death and Differentiation.
[55] K. Shimoke,et al. Nerve growth factor prevents 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced cell death via the Akt pathway by suppressing caspase‐3‐like activity using PC12 cells: Relevance to therapeutical application for parkinson's disease , 2001, Journal of neuroscience research.
[56] N. Tatton. Increased Caspase 3 and Bax Immunoreactivity Accompany Nuclear GAPDH Translocation and Neuronal Apoptosis in Parkinson's Disease , 2000, Experimental Neurology.
[57] P. Cohen,et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.
[58] G. Cooper,et al. Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway* , 1998, The Journal of Biological Chemistry.